Expression of a Specific Glycosyltransferase Enzyme Regulates T Cell Death Mediated by Galectin-1*

Galectin-1 induces apoptosis of immature thymocytes and activated T cells, suggesting that galectin-1 regulates cell death in the thymus during selection and in the periphery following an immune response. Although it is known that galectin-1 recognizes lactosamine (Gal-GlcNAc) as a minimal ligand, this disaccharide is ubiquitously expressed on a variety of cell surface glycoproteins. Thus, susceptibility to galectin-1 may be regulated by the presentation of lactosamine on specific oligosaccharide structures created by specific glycosyltransferase enzymes. The core 2 β-1,6-N-acetylglucosaminyltransferase (core 2 GnT) creates a branched structure on O-glycans that can be elongated to present multiple lactosamine sequences. In the thymus, the core 2 GnT is expressed in galectin-1-sensitive thymocyte subsets. In the periphery, an oligosaccharide epitope created by the core 2 GnT is expressed on galectin-1-sensitive activated T-cells. In this report, we demonstrate that expression of the core 2 GnT was necessary and sufficient for galectin-1-induced death of murine T cell lines. In addition, overexpression of the core 2 GnT in mice increased the susceptibility of double positive thymocytes to galectin-1. These data demonstrate that expression of a specific glycosyltransferase can control susceptibility to galectin-1, suggesting that developmentally regulated glycosyltransferase expression may be a mechanism to modulate cell death during T cell development and function.

[1]  J. Altman,et al.  Differentiating between Memory and Effector Cd8 T Cells by Altered Expression of Cell Surface O-Glycans , 2000, The Journal of experimental medicine.

[2]  P. Stewart,et al.  Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. , 1999, Journal of immunology.

[3]  D. A. Carlow,et al.  A novel CD8 T cell-restricted CD45RB epitope shared by CD43 is differentially affected by glycosylation. , 1999, Journal of immunology.

[4]  M. Fukuda,et al.  Poly-N-acetyllactosamine Synthesis in BranchedN-Glycans Is Controlled by Complemental Branch Specificity of i-Extension Enzyme and β1,4-Galactosyltransferase I* , 1999, The Journal of Biological Chemistry.

[5]  M. Peter,et al.  Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/Fas)-mediated apoptosis and for infection by a lymphotropic virus. , 1999, Glycobiology.

[6]  K. Moremen,et al.  Enzymatic synthesis of natural and 13C enriched linear poly-N-acetyllactosamines as ligands for galectin-1. , 1999, Glycobiology.

[7]  S. Iwata,et al.  CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response. , 1999, International immunology.

[8]  L. A. Lewis,et al.  Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation. , 1999, Journal of immunology.

[9]  O Hindsgaul,et al.  Synthesis of Poly-N-acetyllactosamine in Core 2 Branched O-Glycans , 1998, The Journal of Biological Chemistry.

[10]  S. Tsuboi,et al.  Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. , 1998, Immunity.

[11]  M. Bevan,et al.  T-cell selection. , 1998, Current opinion in immunology.

[12]  S. Tsuboi,et al.  Branched O‐linked oligosaccharides ectopically expressed in transgenic mice reduce primary T‐cell immune responses , 1997, The EMBO journal.

[13]  A. Suzuki,et al.  Tissue-specific Regulation of Mouse Core 2 β-1,6-N-Acetylglucosaminyltransferase* , 1997, The Journal of Biological Chemistry.

[14]  L. Baum,et al.  Galectin-1, an Endogenous Lectin Produced by Thymic Epithelial Cells, Induces Apoptosis of Human Thymocytes , 1997, The Journal of experimental medicine.

[15]  J. Dennis,et al.  Modification of CD43 and other lymphocyte O-glycoproteins by core 2 N-acetylglucosaminyltransferase. , 1997, Glycobiology.

[16]  L. Ellies,et al.  The CD43 130-kD peripheral T-cell activation antigen is downregulated in thymic positive selection. , 1996, Blood.

[17]  M. Pang,et al.  Characterization of Terminal Sialic Acid Linkages on Human Thymocytes , 1996, The Journal of Biological Chemistry.

[18]  L. Baum,et al.  Apoptosis of T cells mediated by galectin-1 , 1995, Nature.

[19]  M. Fukuda,et al.  Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells , 1995, The Journal of experimental medicine.

[20]  C. Smith,et al.  Characterization of the activation-associated isoform of CD43 on murine T lymphocytes. , 1994, Journal of immunology.

[21]  R. Cummings,et al.  Modification of glycoproteins by N-acetylglucosaminyltransferase V is greatly influenced by accessibility of the enzyme to oligosaccharide acceptors. , 1994, The Journal of biological chemistry.

[22]  S. Barondes,et al.  Galectins. Structure and function of a large family of animal lectins. , 1994, The Journal of biological chemistry.

[23]  M. Fukuda,et al.  Expression of a differentiation antigen and poly-N-acetyllactosaminyl O-glycans directed by a cloned core 2 beta-1,6-N-acetylglucosaminyltransferase. , 1994, The Journal of biological chemistry.

[24]  D. Wen,et al.  Isolation, characterization, and expression of a cDNA encoding N-acetylglucosaminyltransferase V. , 1993, The Journal of biological chemistry.

[25]  M. Fukuda,et al.  Poly-N-acetyllactosaminyl O-glycans attached to leukosialin. The presence of sialyl Le(x) structures in O-glycans. , 1992, The Journal of biological chemistry.

[26]  K. Weinberg,et al.  Altered O-glycan synthesis in lymphocytes from patients with Wiskott- Aldrich syndrome , 1991, The Journal of experimental medicine.

[27]  J. Dennis,et al.  Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. , 1991, The Journal of biological chemistry.

[28]  M. Fukuda,et al.  T-lymphocytic leukemia expresses complex, branched O-linked oligosaccharides on a major sialoglycoprotein, leukosialin. , 1991, Blood.

[29]  I. Brockhausen,et al.  Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDP-GlcNAc:Gal beta 3 GalNAc alpha-R (GlcNAc to GalNAc) beta(1-6)-N-acetylglucosaminyltransferase in leukemic cells. , 1991, Cancer research.

[30]  J. Dennis,et al.  Increased UDP-GlcNAc:Gal beta 1-3GaLNAc-R (GlcNAc to GaLNAc) beta-1, 6-N-acetylglucosaminyltransferase activity in metastatic murine tumor cell lines. Control of polylactosamine synthesis. , 1991, The Journal of biological chemistry.

[31]  R. Cummings,et al.  Asparagine-linked oligosaccharides containing poly-N-acetyllactosamine chains are preferentially bound by immobilized calf heart agglutinin. , 1988, The Journal of biological chemistry.

[32]  M. Fukuda,et al.  Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. , 1988, The Journal of biological chemistry.

[33]  D. H. van den Eijnden,et al.  Biosynthesis of blood group i-active polylactosaminoglycans. Partial purification and properties of an UDP-GlcNAc:N-acetyllactosaminide beta 1----3-N-acetylglucosaminyltransferase from Novikoff tumor cell ascites fluid. , 1988, The Journal of biological chemistry.

[34]  S. Barondes,et al.  Multiple soluble beta-galactoside-binding lectins from human lung. , 1987, The Journal of biological chemistry.

[35]  A. Dell,et al.  Structures of O-linked oligosaccharides isolated from normal granulocytes, chronic myelogenous leukemia cells, and acute myelogenous leukemia cells. , 1986, The Journal of biological chemistry.

[36]  K. Kasai,et al.  Photochemical cross-linking of beta-galactoside-binding lectin to polylactosamino-proteoglycan of chick embryonic skin. , 1984, Biochemical and biophysical research communications.

[37]  A. Kobata,et al.  Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis. , 1984, The Journal of biological chemistry.

[38]  R. Fox,et al.  A novel cell surface antigen (T305) found in increased frequency on acute leukemia cells and in autoimmune disease states. , 1983, Journal of immunology.

[39]  R. Cummings,et al.  A mouse lymphoma cell line resistant to the leukoagglutinating lectin from Phaseolus vulgaris is deficient in UDP-GlcNAc: alpha-D-mannoside beta 1,6 N-acetylglucosaminyltransferase. , 1982, The Journal of biological chemistry.

[40]  I. Trowbridge,et al.  Expression of Thy‐1 glycoprotein on lectin‐resistant lymphoma cell lines , 1978, European journal of immunology.

[41]  N. Watanabe,et al.  Positive and negative thymocyte selection. , 1998, Critical reviews in immunology.

[42]  H. von Boehmer,et al.  Development and selection of T cells: facts and puzzles. , 1995, Advances in immunology.